Does intravenous 6-mercaptopurine decrease salvage after relapse in childhood acute lymphoblastic leukemia?
Mahoney
Donald H
DH
Camitta
Bruce M
BM
Devidas
Meenakshi
M
D000284:Administration, Oral; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018572:Disease-Free Survival; D006801:Humans; D007262:Infusions, Intravenous; D015122:Mercaptopurine / Q000008:administration & dosage*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D016879:Salvage Therapy
D000964:Antimetabolites, Antineoplastic; D015122:Mercaptopurine